A Clinical Trial to Evaluate the Recombinant Human Type5 Adenovirus Vector Based Ebola Virus Disease Vaccine

NCT02575456 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

500

Enrollment

NETWORK

Sponsor class

Conditions

Ebola Disease

Interventions

BIOLOGICAL: Ebola Vaccine
BIOLOGICAL: Placebo

Sponsor

Jiangsu Province Centers for Disease Control and Prevention

Collaborators

[object Object]
[object Object]